<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Descriptors of Malignant Non-mass Enhancement of Breast MRI" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/descriptors-of-malignant-non-mass-enhancement-of-breast-mri/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/descriptors-of-malignant-non-mass-enhancement-of-breast-mri/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2016-05-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Descriptors of Malignant Non-mass Enhancement of Breast MRI" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2016-05-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Descriptors of Malignant Non-mass Enhancement of Breast MRI","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/descriptors-of-malignant-non-mass-enhancement-of-breast-mri/"},"url":"https://clinicaltree.github.io/posts/descriptors-of-malignant-non-mass-enhancement-of-breast-mri/"}</script><title>Descriptors of Malignant Non-mass Enhancement of Breast MRI | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Descriptors of Malignant Non-mass Enhancement of Breast MRI</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Descriptors of Malignant Non-mass Enhancement of Breast MRI</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1464714000" data-df="ll" data-toggle="tooltip" data-placement="bottom"> May 31, 2016 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Youichi Machida MD PhD</a> </em>, <em> <a href="">Akiko Shimauchi MD PhD</a> </em>, <em> <a href="">Mitsuhiro Tozaki MD PhD</a> </em>, <em> <a href="">Yoshifumi Kuroki MD PhD</a> </em>, <em> <a href="">Tamiko Yoshida MD</a> </em>, <em> <a href="">Eisuke Fukuma MD PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2101 words"> <em>11 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>This study aims to investigate the clinical significance of malignant non-mass enhancement (NME) descriptors in breast magnetic resonance images by assessing their correlation to the presence of invasion or lymph node metastasis.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Three radiologists independently reviewed magnetic resonance images with malignant NMEs between January 2008 and December 2009. Distribution was assessed first, and then each of four internal enhancement patterns—clumped, clustered ring, branching, and hypointense area—was evaluated dichotomously (yes or no). Because clustered rings and hypointense areas were thought to be major structural elements of heterogeneous NMEs, they were also evaluated by integrating them into one collective descriptor we called the “heterogeneous structures.” Chi-square test, Fisher exact test, or Student <em>t</em> test was used to analyze differences of variables by each reviewer. Positive predictive values (PPVs) of descriptors in predicting presence of invasion or lymph node metastasis were calculated. <em>P</em> &lt; 0.05 was considered significant.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>We included 131 malignant NMEs (76 in situ and 55 invasive) in 129 patients (two bilateral). All three observers’ results showed clustered rings (PPVs 54.5%, 54.5%, 50.0%) ( <em>P</em> = 0.0005, 0.038, 0.029) and hypointense areas (PPVs 63.6%, 61.5%, 73.9%) ( <em>P</em> = 0.004, 0.024, 0.0006) to be significantly associated with invasion. When clustered rings and hypointense areas were integrated into heterogeneous structures, they were significantly associated with invasion (PPVs 54.3%, 53.3%, 51.8%) ( <em>P</em> = 0.0003, 0.016, 0.003).</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The NME descriptors clustered rings, hypoechoic areas, and heterogeneous structures, assessed collectively, were associated with invasive breast cancer.</p><h2 id="introduction"><span class="mr-2">Introduction</span><a href="#introduction" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Non-mass enhancement (NME) is one of the three lesion morphologies observed in magnetic resonance imaging (MRI) of breasts and is often associated with in situ lesions . However, NMEs with invasive components reportedly account for 10%–42% of total malignant NMEs . In situ and invasive lesions should be managed differently, especially when recent controversy about overtreatment of in situ breast cancer is taken into account .</p><p>Breast Imaging Reporting and Data System (BI-RADS) descriptors have been investigated in differentiating benign from malignant NME . However, few prior studies have investigated relationships between descriptors of NMEs and significant clinical factors, including invasion within NMEs . Furthermore, other internal structural patterns within NMEs, which are not widely recognized or have not been adopted into MR lexicon at this point, are also encountered in clinical practice. For example, fine branching structures within NMEs that suggest possible enhancement within or around ducts and their branches have been associated with malignancy ( Fig 1c , called “branching” in this study). In addition, within NMEs, relatively hypointense, confined areas that show fewer enhancements than surrounding areas are occasionally observed ( Figs 1d, 3b, 4b, 5b ; called “hypointense areas” in this study). We believe that this finding seems to add another major structural element of heterogeneous NMEs in addition to the clustered ring, given that heterogeneous NMEs are supposed to include areas of varying enhancement.</p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DescriptorsofMalignantNonmassEnhancementofBreastMRI/0_1s20S1076633216000994.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DescriptorsofMalignantNonmassEnhancementofBreastMRI/0_1s20S1076633216000994.jpg" alt="Figure 1, Sagittal contrast-enhanced T1-weighted images showing examples of internal enhancement patterns (IEPs). (a) 49-year-old woman with ductal carcinoma in situ (DCIS) of the left breast; non-mass enhancement (NME) includes a clumped IEP ( arrowheads ). (b) 38-year-old woman with invasive carcinoma of no special type (NST) of the right breast; NME includes a clustered ring IEP ( arrowheads ). (c) 47-year-old woman with DCIS of the right breast; NME includes branching IEP ( arrows ). (d) 48-year-old woman with invasive NST of the left breast; NME includes a hypointense area IEP ( circle )." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="patients"><span class="mr-2">Patients</span><a href="#patients" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mri-technique"><span class="mr-2">MRI Technique</span><a href="#mri-technique" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="observer-study"><span class="mr-2">Observer Study</span><a href="#observer-study" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analyses"><span class="mr-2">Statistical Analyses</span><a href="#statistical-analyses" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="study-subjects-and-lesions"><span class="mr-2">Study Subjects and Lesions</span><a href="#study-subjects-and-lesions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="analysis-between-mri-descriptors-and-clinical-factors"><span class="mr-2">Analysis Between MRI Descriptors and Clinical Factors</span><a href="#analysis-between-mri-descriptors-and-clinical-factors" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>TABLE 1</p><p>Analyses Between MRI Descriptors Assessed by Reviewer 1 and Clinical Outcomes</p><p>Invasive In Situ PPV (95%CI) NPV (95%CI)<em>P</em> Distribution 0.82 Diffuse 1 2 Focal 6 7 Linear 0 1 Multiple 0 0 Regional 0 0 Segmental 48 66 Clumped +/− 33/22 53/23 38.4% (28.1–48.7%) 51.1% (36.5–65.7%) 0.25 Branching +/− 39/16 58/18 40.2% (30.4–50.0%) 52.9% (36.2–69.7%) 0.49 Heterogeneous structure +/− 44/11 37/39 54.3% (43.5–65.2%) 78.0% (66.5–89.5%) 0.0003 Clustered ring +/− 42/13 35/41 54.5% (43.4–65.7%) 75.9% (64.5–87.3%) 0.0005 Hypointense area +/− 21/34 12/64 63.6% (47.2–80.0%) 65.3% (55.9–74.7%) 0.004</p><p>LNM + − PPV (95%CI) NPV (95%CI)<em>P</em> Distribution 0.77 Diffuse 0 1 Focal 2 4 Linear 0 0 Regional 0 0 Segmental 13 37 Clumped +/− 5/8 28/14 15.2% (2.9–27.4%) 63.6% (43.5–83.7%) 0.11 Branching +/− 7/6 32/10 17.9% (5.9–30.0%) 62.5% (38.8–86.2%) 0.23 Heterogeneous structure +/− 12/1 32/10 27.3% (14.1–40.4%) 90.9% (73.9–100.0%) 0.27 Clustered ring +/− 12/1 30/12 28.6% (14.9–42.2%) 92.3% (77.8–100.0%) 0.16 Hypointense area +/− 4/9 17/25 19.0% (2.3–35.8%) 73.5% (58.7–88.4%) 0.75</p><p>CI, confidence interval; LNM, lymph node metastasis; NPV, negative predictive value; PPV, positive predictive value.</p><p>TABLE 2</p><p>Analyses Between MRI Descriptors Assessed by Reviewer 2 and Clinical Outcomes</p><p>Invasive In Situ PPV (95%CI) NPV (95%CI)<em>P</em> Distribution 0.76 Diffuse 0 0 Focal 10 13 Linear 5 10 Multiple 0 1 Regional 3 2 Segmental 37 50 Clumped +/− 36/19 57/19 38.7% (28.8–48.6%) 50.0% (34.1–65.9%) 0.23 Branching +/− 29/26 39/37 42.6% (30.9–54.4%) 58.7% (46.6–70.9%) 0.87 Heterogeneous structure +/− 32/23 28/48 53.3% (40.7–66.0%) 67.6% (56.7–78.5%) 0.016 Clustered ring +/− 24/31 20/56 54.5% (39.8–69.3%) 64.4% (54.4–74.4%) 0.038 Hypointense area +/− 16/39 10/66 61.5% (42.8–80.2%) 62.9% (53.6–72.1%) 0.024</p><p>LNM + − PPV (95%CI) NPV (95%CI)<em>P</em> Distribution 0.18 Diffuse 0 0 Focal 3 7 Linear 0 5 Regional 2 1 Segmental 8 29 Clumped +/− 7/6 29/13 19.4% (6.5–32.4%) 68.4% (47.5–89.3%) 0.50 Branching +/− 7/6 22/20 24.1% (8.6–39.7%) 76.9% (60.7–93.1%) 0.93 Heterogeneous structure +/− 9/4 23/19 28.1% (12.5–43.7%) 82.6% (67.1–98.1%) 0.52 Clustered ring +/− 6/7 18/24 25.0% (7.7–42.3%) 77.4% (62.7–92.1%) 0.83 Hypointense area +/− 4/9 12/30 25.0% (3.8–46.2%) 76.9% (63.7–90.1%) 1.0</p><p>CI, confidence interval; LNM, lymph node metastasis; NPV, negative predictive value; PPV, positive predictive value.</p><p>TABLE 3</p><p>Analyses Between MRI Descriptors Assessed by Reviewer 3 and Clinical Outcomes</p><p>Invasive In Situ PPV (95%CI) NPV (95%CI)<em>P</em> Distribution 0.19 Diffuse 0 0 Focal 4 9 Linear 1 1 Multiple 0 0 Regional 0 5 Segmental 50 61 Clumped +/− 41/14 61/15 40.2% (30.7–49.7%) 51.7% (33.5–69.9%) 0.44 Branching +/− 42/13 49/27 46.2% (35.9–56.4%) 67.5% (53.0–82.0%) 0.14 Heterogeneous structure +/− 43/12 40/36 51.8% (41.1–62.6%) 51.8% (41.1–62.6%) 0.003 Clustered ring +/− 38/17 38/38 50.0% (38.8–61.2%) 69.1% (56.9–81.3%) 0.029 Hypointense area +/− 17/38 6/70 73.9% (56.0–91.9%) 64.8% (55.8–73.8%) 0.0006</p><p>LNM + − PPV (95%CI) NPV (95%CI)<em>P</em> Distribution 0.85 Diffuse 0 0 Focal 1 3 Linear 0 1 Regional 0 0 Segmental 12 38 Clumped +/− 10/3 31/11 24.4% (11.2–37.5%) 78.6% (57.1–100.0%) 1.0 Branching +/− 7/6 35/7 16.7% (5.4–27.9%) 53.8% (26.7–80.9%) 0.07 Heterogeneous structure +/− 12/1 31/11 27.9% (14.5–41.3%) 91.7% (76.0–100.0%) 0.26 Clustered ring +/− 12/1 26/16 31.6% (16.8–46.4%) 94.1% (82.9–100.0%) 0.045 Hypointense area +/− 5/8 12/30 29.4% (7.8–51.1%) 78.9% (66.0–91.9%) 0.51</p><p>CI, confidence interval; LNM, lymph node metastasis; NPV, negative predictive value; PPV, positive predictive value.</p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DescriptorsofMalignantNonmassEnhancementofBreastMRI/1_1s20S1076633216000994.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DescriptorsofMalignantNonmassEnhancementofBreastMRI/1_1s20S1076633216000994.jpg" alt="Figure 2, 61-year-old woman with invasive carcinoma of no special type (NST) of the left breast. Anteroposterior Maximum intensity projection (MIP) of subtraction image (a) and sagittal contrast-enhanced T1-weighted image (b) are shown. The distribution of this non-mass enhancement (NME) was interpreted as segmental by Reviewers 1 and 3 and as regional by Reviewer 2. Clustered ring internal enhancement pattern was detected by all three reviewers ( arrowheads ). Axillary lymph node metastasis was detected in the histopathological analysis." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DescriptorsofMalignantNonmassEnhancementofBreastMRI/2_1s20S1076633216000994.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DescriptorsofMalignantNonmassEnhancementofBreastMRI/2_1s20S1076633216000994.jpg" alt="Figure 3, 42-year-old woman with invasive carcinoma of no special type (NST) of the right breast. Coronal (a) and sagittal (b) contrast-enhanced T1-weighted images are shown. All three reviewers interpreted this non-mass enhancement (NME) as segmental distribution, with a hypointense area ( circle ). No metastasis was seen in histopathological analysis of biopsied sentinel lymph nodes." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="interobserver-agreement-of-descriptors"><span class="mr-2">Interobserver Agreement of Descriptors</span><a href="#interobserver-agreement-of-descriptors" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>TABLE 4</p><p>Interobserver Agreement of Descriptors Between Reviewers Expressed as Kappa Values</p><p>Reviewers Distribution Clumped Branching Heterogeneous Structure Clustered Ring Hypointense Area 1 vs 2 0.32 (0.19–0.45) 0.35 (0.18–0.52) 0.18 (0.02–0.33) 0.51 (0.37–0.64) 0.41 (0.28–0.54) 0.54 (0.37–0.71) 1 vs 3 0.26 (0.14–0.38) 0.41 (0.24–0.57) 0.29 (0.11–0.46) 0.51 (0.36–0.66) 0.42 (0.26–0.58) 0.37 (0.18–0.56) 2 vs 3 0.45 (0.31–0.59) 0.42 (0.25–0.60) 0.40 (0.25–0.54) 0.45 (0.31–0.59) 0.42 (0.29–0.55) 0.57 (0.39–0.75)</p><p>The 95% confidence intervals are shown in parentheses.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DescriptorsofMalignantNonmassEnhancementofBreastMRI/3_1s20S1076633216000994.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DescriptorsofMalignantNonmassEnhancementofBreastMRI/3_1s20S1076633216000994.jpg" alt="Figure 4, 47-year-old woman with invasive carcinoma of no special type (NST) of the left breast. Anteroposterior MIP of subtraction image (a) and sagittal contrast-enhanced T1-weighted image (b) are shown. All three reviewers interpreted this non-mass enhancement (NME) as segmental distribution, with a clustered ring ( arrow ) and hypointense areas ( arrowheads ). No metastasis was seen in the histopathological analysis of biopsied sentinel lymph nodes." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DescriptorsofMalignantNonmassEnhancementofBreastMRI/4_1s20S1076633216000994.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DescriptorsofMalignantNonmassEnhancementofBreastMRI/4_1s20S1076633216000994.jpg" alt="Figure 5, 48-year-old woman with invasive carcinoma of no special type (NST) of the left breast. Anteroposterior MIP of subtraction image (a) and sagittal contrast-enhanced T1-weighted image (b) are shown. All three reviewers interpreted this non-mass enhancement (NME) as segmental distribution, with a clustered ring ( arrow ). Hypointense areas ( arrowheads ) were also pointed out by Reviewers 1 and 2 but were not indicated by Reviewer 3. No metastasis was seen in the histopathological analysis of biopsied sentinel lymph nodes." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgment"><span class="mr-2">Acknowledgment</span><a href="#acknowledgment" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Liberman L., Morris E.A., Lee M.J., et. al.: Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol 2002; 179: pp. 171-178.</p><li><p>2. Jansen S.A., Shimauchi A., Zak L., et. al.: The diverse pathology and kinetics of mass, nonmass, and focus enhancement on MR imaging of the breast. J Magn Reson Imaging 2011; 33: pp. 1382-1389.</p><li><p>3. Jiang L., Zhou Y., Wang Z., et. al.: Is there different correlation with prognostic factors between “non-mass” and “mass” type invasive ductal breast cancers?. Eur J Radiol 2013; 82: pp. 1404-1409.</p><li><p>4. Goto M., Yuen S., Akazawa K., et. al.: The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy. Eur Radiol 2012; 22: pp. 1255-1264.</p><li><p>5. Francis A., Thomas J., Fallowfield L., et. al.: Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer 2015; 51: pp. 2296-2303.</p><li><p>6. Hersch J., Barratt A., Jansen J., et. al.: Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet 2015; 385: pp. 1642-1652.</p><li><p>7. Gur D., Sumkin J.H.: Screening for early detection of breast cancer: overdiagnosis versus suboptimal patient management. Radiology 2013; 268: pp. 327-328.</p><li><p>8. Gutierrez R.L., DeMartini W.B., Eby P.R., et. al.: BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement. AJR Am J Roentgenol 2009; 193: pp. 994-1000.</p><li><p>9. Mahoney M.C., Gatsonis C., Hanna L., et. al.: Positive predictive value of BI-RADS MR imaging. Radiology 2012; 264: pp. 51-58.</p><li><p>10. Pinker-Domenig K., Bogner W., Gruber S., et. al.: High resolution MRI of the breast at 3 T: which BI-RADS(R) descriptors are most strongly associated with the diagnosis of breast cancer?. Eur Radiol 2012; 22: pp. 322-330.</p><li><p>11. Tozaki M., Fukuda K.: High-spatial-resolution MRI of non-masslike breast lesions: interpretation model based on BI-RADS MRI descriptors. AJR Am J Roentgenol 2006; 187: pp. 330-337.</p><li><p>12. Uematsu T., Kasami M.: High-spatial-resolution 3-T breast MRI of nonmasslike enhancement lesions: an analysis of their features as significant predictors of malignancy. AJR Am J Roentgenol 2012; 198: pp. 1223-1230.</p><li><p>13. Baltzer P.A., Benndorf M., Dietzel M., et. al.: False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study. AJR Am J Roentgenol 2010; 194: pp. 1658-1663.</p><li><p>14. Baltzer P.A., Dietzel M., Kaiser W.A.: Nonmass lesions in magnetic resonance imaging of the breast: additional T2-weighted images improve diagnostic accuracy. J Comput Assist Tomogr 2011; 35: pp. 361-366.</p><li><p>15. Hahn S.Y., Han B.K., Ko E.Y., et. al.: MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?. Acta Radiol 2013; 54: pp. 742-748.</p><li><p>16. Machida Y., Tozaki M., Shimauchi A., et. al.: Two distinct types of linear distribution in nonmass enhancement at breast MR imaging: difference in positive predictive value between linear and branching patterns. Radiology 2015; 276: pp. 686-694.</p><li><p>17. Yabuuchi H., Matsuo Y., Kamitani T., et. al.: Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. Eur J Radiol 2010; 75: pp. e126-e132.</p><li><p>18. Sakamoto N., Tozaki M., Higa K., et. al.: Categorization of non-mass-like breast lesions detected by MRI. Breast Cancer 2008; 15: pp. 241-246.</p><li><p>19. Tozaki M., Igarashi T., Fukuda K.: Breast MRI using the VIBE sequence: clustered ring enhancement in the differential diagnosis of lesions showing non-masslike enhancement. AJR Am J Roentgenol 2006; 187: pp. 313-321.</p><li><p>20. Christofori G.: New signals from the invasive front. Nature 2006; 441: pp. 444-450.</p><li><p>21. Newell D., Nie K., Chen J.H., et. al.: Selection of diagnostic features on breast MRI to differentiate between malignant and benign lesions using computer-aided diagnosis: differences in lesions presenting as mass and non-mass-like enhancement. Eur Radiol 2010; 20: pp. 771-781.</p><li><p>22. Goto M., Ito H., Akazawa K., et. al.: Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features. J Magn Reson Imaging 2007; 25: pp. 104-112.</p><li><p>23. Jansen S.A., Fan X., Karczmar G.S., et. al.: DCEMRI of breast lesions: is kinetic analysis equally effective for both mass and nonmass-like enhancement?. Med Phys 2008; 35: pp. 3102-3109.</p><li><p>24. Jansen S.A., Newstead G.M., Abe H., et. al.: Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology 2007; 245: pp. 684-691.</p><li><p>25. Kuhl C.: The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007; 244: pp. 356-378.</p><li><p>26. Fischer U., Vosshenrich R., Kopka L., et. al.: [Contrast medium assisted dynamic MR-mammography after diagnostic and therapeutic interventions on the breast]. Bildgebung 1996; 63: pp. 94-100.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-23/'>Volume 23</a>, <a href='/categories/issue-6/'>Issue 6</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Descriptors%20of%20Malignant%20Non-mass%20Enhancement%20of%20Breast%20MRI%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fdescriptors-of-malignant-non-mass-enhancement-of-breast-mri%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Descriptors%20of%20Malignant%20Non-mass%20Enhancement%20of%20Breast%20MRI%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fdescriptors-of-malignant-non-mass-enhancement-of-breast-mri%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fdescriptors-of-malignant-non-mass-enhancement-of-breast-mri%2F&text=Descriptors%20of%20Malignant%20Non-mass%20Enhancement%20of%20Breast%20MRI%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/anatomic-eponyms-in-neuroradiology-brain-cerebral-vasculature-and-calvarium/"><div class="card-body"> <em class="small" data-ts="1464714000" data-df="ll" > May 31, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Anatomic Eponyms in Neuroradiology Brain, Cerebral Vasculature, and Calvarium</h3><div class="text-muted small"><p> Medical eponyms are ubiquitous, numerous, and at times controversial. They are often useful for succinctly conveying complex concepts, and familiarity with eponyms is important for proper usage and...</p></div></div></a></div><div class="card"> <a href="/posts/associations-between-nih-funding-and-advanced-bibliometric-indices-among-radiological-investigators/"><div class="card-body"> <em class="small" data-ts="1464714000" data-df="ll" > May 31, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Associations Between NIH Funding and Advanced Bibliometric Indices Among Radiological Investigators</h3><div class="text-muted small"><p> Rationale and Objectives Whereas data support the h index (reflecting both publications and citations) as an indicator of academic productivity, other advanced bibliometric indices aiming to addre...</p></div></div></a></div><div class="card"> <a href="/posts/diagnostic-accuracy-image-quality-and-patient-comfort-for-coronary-ct-angiography-performed-using/"><div class="card-body"> <em class="small" data-ts="1464714000" data-df="ll" > May 31, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Diagnostic Accuracy, Image Quality, and Patient Comfort for Coronary CT Angiography Performed Using Iso-Osmolar versus Low-Osmolar Iodinated Contrast</h3><div class="text-muted small"><p> Rationale and Objectives The impact of iso-osmolar versus low-osmolar iodinated contrast on diagnostic accuracy for coronary computed tomography angiography (CCTA), against the reference standard ...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/associations-between-nih-funding-and-advanced-bibliometric-indices-among-radiological-investigators/" class="btn btn-outline-primary" prompt="Older"><p>Associations Between NIH Funding and Advanced Bibliometric Indices Among Radiological Investigators</p></a> <a href="/posts/diagnostic-accuracy-image-quality-and-patient-comfort-for-coronary-ct-angiography-performed-using/" class="btn btn-outline-primary" prompt="Newer"><p>Diagnostic Accuracy, Image Quality, and Patient Comfort for Coronary CT Angiography Performed Using Iso-Osmolar versus Low-Osmolar Iodinated Contrast</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
